RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases

PURPOSE: RAS mutations have been reported to be a potential prognostic factor in patients with colorectal liver metastases (CLM). However, the impact of RAS mutations on response to chemotherapy remains unclear. We sought to determine the association between RAS mutations and response to preoperativ...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Surg Oncol
Asıl Yazarlar: Zimmitti, Giuseppe, Shindoh, Junichi, Mise, Yoshihiro, Kopetz, Scott, Loyer, Evelyne M., Andreou, Andreas, Cooper, Amanda B., Kaur, Harmeet, Aloia, Thomas A., Maru, Dipen M., Vauthey, Jean-Nicolas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318708/
https://ncbi.nlm.nih.gov/pubmed/25227306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4042-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller